The All India Institute of Medical Science (AIIMS), Delhi, will start from Monday screening for the clinical trials of the homegrown anti-Covid vaccine, Covaxin, on children, sources say. This comes days after AIIMS Patna started the trials on children.
Experts have warned that a possible third wave can bring as much devastation as the second wave of the pandemic if enough people are not vaccinated against the virus, and that children could be its prime target.
